Despite increasing investments and rising costs, the pharmaceutical industry's internal rate of return (IRR) from research and development (R&D) has been on a downward trajectory for decades. Recently, however, an analysis indicates the possibility of a resurgence in R&D returns, a development that
Victoria has embarked on a groundbreaking journey aiming to establish itself as a leading force in global cancer research. Through the Cancer Council Research Fellowships Victoria (CRFV) program, the Victorian Government, in collaboration with Cancer Council Victoria, seeks to reshape the landscape
In a remarkable breakthrough for stem cell research, a team of Australian scientists from Magellan Stem Cells has been celebrated globally for their pioneering work in osteoarthritis clinical research. These researchers have received the esteemed Research Publication of the Year Award from a
Recent research spearheaded by the University of California, San Diego, alongside international collaborators, has uncovered a potentially vital link between the bacterial toxin colibactin and rising colorectal cancer cases among individuals under the age of 50. Published in Nature, the study
In an era increasingly defined by scientific breakthroughs, the landscape of cancer treatment is witnessing transformative changes poised to revolutionize patient care. Recent developments, including innovative trials presented at The University of Texas MD Anderson Cancer Center during the AACR
The development of SENTI-202, which leverages engineered chimeric antigen receptor natural killer (CAR NK) cells, signifies a significant advancement in the treatment landscape for relapsed or refractory acute myeloid leukemia (AML). Presented at the American Association for Cancer Research Annual
